Liu Xiao-Yu, Jia Hui-Yang, Wang Gang
Department of Radiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Department of Neurology, Panjin Central Hospital, Jinzhou Medical University, Panjin, China.
Front Neurol. 2025 May 1;16:1465508. doi: 10.3389/fneur.2025.1465508. eCollection 2025.
This study aimed to explore the factors associated with hemorrhagic transformation (HT) in acute ischemic stroke patients after intravenous thrombolysis (IVT), with a specific focus on the relationship with the post-thrombolysis fibrinogen-to-albumin ratio (FAR).
The clinical records of 569 acute ischemic stroke (AIS) patients admitted to our department from 2020 to 2023 were retrospectively analyzed. All eligible patients were stratified into HT and non-HT (NHT) groups. Propensity score matching (PSM) was performed between the two groups. Receiver operating characteristic (ROC) curves were used to assess the predictive performance of the FAR, determining the optimal predictive value.
Ultimately, 142 patients were included, with 71 in the HT group and 71 in the NHT group. After propensity score matching, a significant association was observed between the FAR and HT ( = 1.40, 95% CI, 1.187-1.645; <0.001). The ROC curve analysis indicated that the FAR predicted HT after intravenous thrombolysis, with an area under the curve (AUC) value of 0.751 (95% CI, 0.669-0.831; <0.001) and an optimal cutoff value of 0.0918. The corresponding sensitivity and specificity were 78.9 and 60.9%, respectively.
In ischemic stroke patients undergoing IVT, the FAR may serve as a promising biochemical marker for predicting HT following treatment.
本研究旨在探讨急性缺血性卒中患者静脉溶栓(IVT)后出血转化(HT)的相关因素,特别关注溶栓后纤维蛋白原与白蛋白比值(FAR)的关系。
回顾性分析2020年至2023年我院收治的569例急性缺血性卒中(AIS)患者的临床资料。所有符合条件的患者被分为HT组和非HT(NHT)组。对两组进行倾向评分匹配(PSM)。采用受试者工作特征(ROC)曲线评估FAR的预测性能,确定最佳预测值。
最终纳入142例患者,HT组和NHT组各71例。倾向评分匹配后,观察到FAR与HT之间存在显著关联(β = 1.40,95%CI,1.187 - 1.645;P < 0.001)。ROC曲线分析表明,FAR可预测静脉溶栓后的HT,曲线下面积(AUC)值为0.751(95%CI,0.669 - 0.831;P < 0.001),最佳截断值为0.0918。相应的敏感性和特异性分别为78.9%和60.9%。
在接受IVT的缺血性卒中患者中,FAR可能是预测治疗后HT的一个有前景的生化标志物。